Immediate Impact
55 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Mingjing Shen being referenced
Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway
2019
Inhibition of IL‐6‐JAK/Stat3 signaling in castration‐resistant prostate cancer cells enhances the NK cell‐mediated cytotoxicity via alteration of PD‐L1/NKG2D ligand levels
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mingjing Shen | 295 | 243 | 170 | 181 | 29 | 621 | |
| Yong-Nyun Kim | 368 | 188 | 202 | 149 | 23 | 708 | |
| Shenglin Ma | 257 | 177 | 145 | 139 | 29 | 552 | |
| Gang Zhao | 330 | 260 | 130 | 106 | 32 | 667 | |
| Serena De Matteis | 272 | 155 | 175 | 114 | 32 | 631 | |
| Yongri Ouyang | 309 | 178 | 253 | 113 | 25 | 589 | |
| Xueying Wang | 233 | 189 | 119 | 109 | 27 | 588 | |
| Carly Bess Scalise | 288 | 266 | 127 | 252 | 30 | 654 | |
| Olsi Gjyshi | 191 | 156 | 140 | 75 | 23 | 519 | |
| Jianjun Jin | 256 | 188 | 165 | 166 | 32 | 606 | |
| Lei Gong | 252 | 159 | 157 | 162 | 37 | 658 |
All Works
Login with ORCID to disown or claim papers
Loading papers...